drugset / Trial / NCT05632315
PMT for MDRO Decolonization
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a randomized, open label, comparative Phase II trial being conducted to determine whether fecal microbiota transplant using Penn Microbiome Therapy (PMT) products helps standard therapy eradicate antibiotic-resistant bacteria.
Timeline
- Start
- 2024-08-19
- Primary completion
- 2026-08
- Completion
- 2026-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PMT-001 | Unknown | — | Rectal |